Patients with ankylosing spondylitis and low disease activity because of anti-TNF-Alpha therapy have higher TRAIL levels than controls: A potential compensatory effect

  1. Genre, F.
  2. López-Mejías, R.
  3. Rueda-Gotor, J.
  4. Miranda-Filloy, J.A.
  5. Ubilla, B.
  6. Carnero-López, B.
  7. Palmou-Fontana, N.
  8. Gómez-Acebo, I.
  9. Blanco, R.
  10. Pina, T.
  11. Ochoa, R.
  12. González-Juanatey, C.
  13. Llorca, J.
  14. González-Gay, M.A.
Revista:
Mediators of Inflammation

ISSN: 1466-1861,  0962-9351

Ano de publicación: 2014

Volume: 2014

Tipo: Artigo

DOI: 10.1155/2014/798060 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus